Table 1 Clinical Characteristics of the Pateints’ Population.

From: Functional Activation of Osteoclast Commitment in Chronic Lymphocytic Leukaemia: a Possible Role for RANK/RANKL Pathway

Group

Number

Gender F/M

AGE (Years)

HEIGHT (cm)

WEIGHT (Kg)

Disease Duration (Months)

Hb (g/L)

WBC (10E9/L)

PLT (10E9/L)

LYMPHOCYTES (RELATIVE %)

%CLONE

IgHV mutation in >2% cells

CD38%

All

36

11/25

70 ± 12

168 ± 8

71 ± 9

34 ± 39

126 ± 22

62,58 ± 55,6

180 ± 56,5

73 ± 20,4

63,24 ± 24,9

22 (61%)

34 ± 22

Binet A

16

6/10

71 ± 13

166 ± 7

66 ± 7

35 ± 33

136,2 ± 14,9

43,7 ± 39

193,3 ± 42,8

68,4 ± 19,4

55,67 ± 21

12 (75%)

30 ± 18

Binet B

12

4/8

67 ± 12

166 ± 9

77 ± 9

39 ± 46

129,6 ± 14

61,1 ± 46,2

77,2 ± 38,9

77,2 ± 14,7

61 ± 30

7 (58%)

38 ± 24

Binet C

8

1/7

73 ± 9

172 ± 7

72 ± 10

23 ± 43

105,5 ± 26,5

102,4 ± 78,1

154 ± 86,5

75,9 ± 28,4

81,7 ± 12

3 (37%)

36 ± 25